The first seven months of 2025 were busy with several medtech acquisitions.
1. Private equity firm Montagu has entered into a definitive agreement to acquire orthopedic device manufacturer Tyber Medical. Along with the acquisition, Tyber has merged with manufacturers Intech and Resolve Surgical Technologies.
2. Stryker sold its U.S. spinal implants business to investment firm Viscogliosi Brothers, which will create VB Spine.
3. Zimmer Biomet acquired Paragon 28, a medical device company focused exclusively on foot and ankle orthopedics.
4. Globus Medical acquired Nevro Corp, a spinal cord stimulator company. Globus Medical’s transaction will include all shares of Nevro, which are valued at about $250 million.
5. Medtronic acquired rights and intellectual property related to Nanovis’ Sites Medical’s OsteoSync titanium pads. Medtronic will use the assets to develop PEEK interbody fusion devices. The FDA-designated bone-growth nanotechnology uses osseointegration to enhance implant fixation.
6. Medacta acquired Parcus Medical, a company that develops products for sports medicine surgery. Parcus Medical will add onto Medacta’s sports medicine and arthroscopy portfolios, and Medacta will take over the company’s U.S. manufacturing site in Florida. Terms of the deal weren’t disclosed.
7. Orthopedic devicemaker Exactech was bought by Strategic Value Partners, an investment firm. The investment firm won a bid to acquire the company and all of its assets. Exactech is expected to present the sale for court approval in March, and the deal is expected to close in May.
8. Xtant Medical sold certain Coflex and CoFix spinal implants and all OUS entities of Paradigm Spine GmbH to Companion Spine. The assets sold for $19.2 million, and Xtant Medical plans to use the money to reduce long-term debt and add to cash liquidity.
